Search Results

There are 6017 results for: content related to: Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists

  1. Pergolide for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    C E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000235

  2. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Article first published online : 20 SEP 2001, DOI: 10.1002/mds.1175

  3. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Article first published online : 6 OCT 2005, DOI: 10.1002/mds.20724

  4. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  5. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 276–280, Ashok Krishnaswami, Kathleen B. Albers, Robin D. Fross, James J. Jang, Sarah B. Berkheimer, Valerie C. Kwai Ben and Stephen K. VanDenEeden

    Article first published online : 9 JAN 2012, DOI: 10.1002/pds.2274

  6. You have free access to this content
    Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

    Journal of Neurochemistry

    Volume 102, Issue 3, August 2007, Pages: 699–711, Evgeny Bychkov, M. Rafiuddin Ahmed, Kevin N. Dalby and Eugenia V. Gurevich

    Article first published online : 21 MAR 2007, DOI: 10.1111/j.1471-4159.2007.04586.x

  7. You have free access to this content
    Cost-Effectiveness of Pergolide Compared to Bromocriptine in the Treatment of Parkinson's Disease: A Decision-Analytic Model

    Value in Health

    Volume 4, Issue 4, July 2001, Pages: 308–315, Peter Davey, Narayan Rajan, Michael Lees and Michael Aristides

    Article first published online : 28 JUN 2008, DOI: 10.1046/j.1524-4733.2001.44039.x

  8. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists

    European Journal of Neurology

    Volume 14, Issue 6, June 2007, Pages: 644–649, A. LLedó, M. A. Dellva, I. M. Strombom, J. L. Wilkie, Mark E. Jungemann, M. G. Royer, V. E. Simmons and P. A. Cavazzoni

    Article first published online : 29 MAY 2007, DOI: 10.1111/j.1468-1331.2007.01801.x

  9. Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000236

  10. Diagnosis and management of pergolide-induced fibrosis

    Movement Disorders

    Volume 19, Issue 6, June 2004, Pages: 699–704, Pinky Agarwal, Stanley Fahn and Steven J. Frucht

    Article first published online : 19 MAY 2004, DOI: 10.1002/mds.20200

  11. Pergolide Mesylate for Cocaine Abuse: A Controlled Preliminary Trial

    The American Journal on Addictions

    Volume 8, Issue 2, Spring 1999, Pages: 120–127, Frances R. Levin, David McDowell, Suzette M. Evans, Daniel Brooks, Christina Spano and Edward V. Nunes

    Article first published online : 18 FEB 2010, DOI: 10.1080/105504999305929

  12. You have free access to this content
    Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: 404–410, Renzo Zanettini, Angelo Antonini, Gemma Gatto, Rosa Gentile, Silvana Tesei and Gianni Pezzoli

    Article first published online : 11 JUN 2010, DOI: 10.1111/j.1755-5922.2010.00169.x

  13. Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor

    Movement Disorders

    Volume 18, Issue 11, November 2003, Pages: 1324–1331, Prithiva Navan, Leslie J. Findley, Jim A.R. Jeffs, Ronald K.B. Pearce and Peter G. Bain

    Article first published online : 12 AUG 2003, DOI: 10.1002/mds.10538

  14. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Katherine Deane, Sybille Spieker and Carl E Clarke

    Published Online : 18 OCT 2004, DOI: 10.1002/14651858.CD004553.pub2

  15. Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1109–1113, Cecilia Peralta, Elisabeth Wolf, Hannes Alber, Klaus Seppi, Silvana Müller, Sylvia Bösch, Gregor K. Wenning, Otmar Pachinger and Werner Poewe

    Article first published online : 18 APR 2006, DOI: 10.1002/mds.20887

  16. A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide

    European Journal of Neurology

    Volume 12, Issue 1, January 2005, Pages: 1–8, P. Navan, L. J. Findley, M. B. Undy, R. K. B. Pearce and P. G. Bain

    Article first published online : 21 DEC 2004, DOI: 10.1111/j.1468-1331.2004.01019.x

  17. You have free access to this content
    Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2267–2302, Claudia Trenkwalder, Wayne A. Hening, Pasquale Montagna, Wolfgang H. Oertel, Richard P. Allen, Arthur S. Walters, Joao Costa, Karin Stiasny-Kolster and Cristina Sampaio

    Article first published online : 16 OCT 2008, DOI: 10.1002/mds.22254

  18. Trial of subtherapeutic pergolide in de novo Parkinson's disease

    Movement Disorders

    Volume 20, Issue 3, March 2005, Pages: 363–366, Katherine Grosset, Donald Grosset and Andrew Lees

    Article first published online : 3 DEC 2004, DOI: 10.1002/mds.20361

  19. A Comparison of Pergolide and Bromocriptine in the Initial Rehabilitation of Cocaine Dependence

    The American Journal on Addictions

    Volume 3, Issue 2, Spring 1994, Pages: 144–150, Robert Malcolm, Joem D. Phillips, Kathleen T. Brady and John R. Roberts

    Article first published online : 18 FEB 2010, DOI: 10.1111/j.1521-0391.1994.tb00381.x

  20. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829